AATD significantly increases the risk of developing chronic obstructive pulmonary disease (COPD), emphysema, and chronic bronchitis, as well as liver cirrhosis, panniculitis, and cytoplasmic anti-neutrophil cytoplasmic autoantibody (c-ANCA)-positive vasculitis. Here, PRTN3 is linked to chronic obstructive pulmonary disease.